• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs.密闭式药物传输系统经济数据回顾:用于危险药物的准备和管理
Eur J Hosp Pharm. 2020 Nov;27(6):361-366. doi: 10.1136/ejhpharm-2018-001775. Epub 2019 Feb 22.
2
Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices.研究综述:考察用于密闭式药物传输装置制备的小瓶中微生物污染情况。
Eur J Hosp Pharm. 2021 Mar;28(2):65-70. doi: 10.1136/ejhpharm-2019-001913. Epub 2019 May 15.
3
Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.使用封闭系统转移装置处理生物药物产品的挑战:行业视角。
J Pharm Sci. 2020 Jan;109(1):22-29. doi: 10.1016/j.xphs.2019.10.042. Epub 2019 Nov 4.
4
Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).评估密闭式输液管路(CSTD)的不同质量相关方面。
Pharm Res. 2020 Apr 9;37(4):81. doi: 10.1007/s11095-020-02784-1.
5
Assessment of unintended volume loss of six closed system transfer devices.六种密闭系统转移装置意外体积损失的评估
J Oncol Pharm Pract. 2020 Jul;26(5):1134-1140. doi: 10.1177/1078155219888682. Epub 2019 Nov 27.
6
Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.封闭系统药物转移装置加危险药物安全操作与仅进行安全操作相比,对减少医护人员接触输注性危险药物的影响
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD012860. doi: 10.1002/14651858.CD012860.pub2.
7
Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs).使用密闭式药物传输装置(CSTD)制备抗癌药物时产生的污染物的频率和成分分析。
Sci Rep. 2022 Jan 7;12(1):139. doi: 10.1038/s41598-021-03780-0.
8
Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents.使用PhaSeal(®)封闭系统转移装置制备抗肿瘤药物所实现的成本节约。
J Oncol Pharm Pract. 2013 Dec;19(4):338-47. doi: 10.1177/1078155213499387. Epub 2013 Aug 23.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.健康经济评估报告标准(CHEERS)——解释与说明:国际卫生经济学会健康经济评估报告指南良好报告实践工作组报告。
Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002.

引用本文的文献

1
Safe handling of cytostatic drugs: recommendations from independent science.安全处理细胞毒性药物:独立科学的建议。
Eur J Hosp Pharm. 2024 Apr 23;31(3):191-196. doi: 10.1136/ejhpharm-2022-003469.
2
[Not Available].[无可用内容]
Can J Hosp Pharm. 2020 Jan-Feb;73(1):27-36. Epub 2020 Feb 1.

本文引用的文献

1
Surface contamination with ten antineoplastic drugs in 83 Canadian centers.加拿大83个中心的十种抗肿瘤药物的表面污染情况。
J Oncol Pharm Pract. 2019 Jul;25(5):1089-1098. doi: 10.1177/1078155218773862. Epub 2018 May 4.
2
Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.封闭系统药物转移装置加危险药物安全操作与仅进行安全操作相比,对减少医护人员接触输注性危险药物的影响
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD012860. doi: 10.1002/14651858.CD012860.pub2.
3
Cost-effectiveness study of closed system transfer devices for the preparation of antineoplastic agents.
Farm Hosp. 2017 Sep 1;41(5):575-582. doi: 10.7399/fh.10702.
4
Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital.马来西亚一家政府资助医院使用封闭系统转移装置(CSTD)进行抗肿瘤药物配制的成本分析
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4951-4957. doi: 10.22034/APJCP.2016.17.11.4951.
5
Comparative study of preparation of hazardous drugs with different closed-system drug transfer devices by means of simulation with fluorescein.通过荧光素模拟对不同密闭式药物转移装置制备危害药物的比较研究。
Farm Hosp. 2016 Nov 1;40(n06):496-503. doi: 10.7399/fh.2016.40.6.10607.
6
Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals.加拿大48家医院中关于环磷酰胺、异环磷酰胺和甲氨蝶呤环境污染的多中心研究。
J Oncol Pharm Pract. 2018 Jan;24(1):9-17. doi: 10.1177/1078155216676632. Epub 2016 Oct 31.
7
Use of closed systems in the Hospital Pharmacy.
Farm Hosp. 2016 Mar 1;40(2):102-10. doi: 10.7399/fh.2016.40.2.9994.
8
Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal , or no closed system transfer device for administration of cancer chemotherapy to a dog model.使用Equashield™、PhaSeal或不使用封闭系统转移装置向犬模型进行癌症化疗给药的治疗时间、易用性和相关成本。
Vet Comp Oncol. 2017 Mar;15(1):163-173. doi: 10.1111/vco.12148. Epub 2015 Apr 10.
9
Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.两种旨在减少危害药物环境污染的方法的影响与评价:静脉输液管在药房预充的集中化以及使用密闭式输液接头。
J Oncol Pharm Pract. 2014 Dec;20(6):426-32. doi: 10.1177/1078155213517127. Epub 2014 Jan 6.
10
Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents.使用PhaSeal(®)封闭系统转移装置制备抗肿瘤药物所实现的成本节约。
J Oncol Pharm Pract. 2013 Dec;19(4):338-47. doi: 10.1177/1078155213499387. Epub 2013 Aug 23.

密闭式药物传输系统经济数据回顾:用于危险药物的准备和管理

Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs.

机构信息

Pharmacy practice research unit, CHU Sainte-Justine, Montreal, QC, Canada.

Faculté de pharmacie, Université de Montréal, Montreal, QC, Canada.

出版信息

Eur J Hosp Pharm. 2020 Nov;27(6):361-366. doi: 10.1136/ejhpharm-2018-001775. Epub 2019 Feb 22.

DOI:10.1136/ejhpharm-2018-001775
PMID:33097620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7856154/
Abstract

OBJECTIVES

The objectives of this study were to review economic data on the use of closed system drug transfer devices (CSTDs) for preparing and administering hazardous drugs, and to evaluate the quality of data reporting as defined by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS).

METHODS

All references from a recent Cochrane review about CSTDs were evaluated for inclusion. A literature review was also conducted. Articles containing economic data about the use of CSTDs were retained for analysis. Two researchers independently graded the articles according to the 24-item CHEERS checklist.

RESULTS

Of the 138 articles identified initially, 12 were retained for analysis. Nine of these studies did not report acquisition costs or did not detail acquisition costs. Six studies reported economic benefits associated with the used of CSTDs, all related to extending the beyond-use date. The mean number of CHEERS criteria fulfilled by the included articles was 9.2 (SD 2.4).

CONCLUSIONS

CSTDs are costly to acquire. However, few studies have examined the economic impact of these devices, and the existing studies are incomplete. As a result, hospitals planning to implement these devices will be unable to make a sound economic evaluation. Robust economic evaluation of CSTDs is needed.

摘要

目的

本研究旨在回顾用于准备和管理危害药物的密闭式药物传输装置(CSTD)的经济数据,并根据统一健康经济评估报告标准(CHEERS)评估数据报告的质量。

方法

评估了最近一篇关于 CSTD 的 Cochrane 综述中的所有参考文献,以确定是否纳入。还进行了文献综述。保留了包含有关 CSTD 使用的经济数据的文章进行分析。两名研究人员根据 24 项 CHEERS 清单独立对文章进行评分。

结果

最初确定的 138 篇文章中,有 12 篇被保留用于分析。其中 9 项研究未报告购置成本或未详细说明购置成本。6 项研究报告了使用 CSTD 的经济效益,均与延长有效期有关。纳入研究的 CHEERS 标准平均满足 9.2 项(SD 2.4)。

结论

CSTD 的购置成本较高。然而,很少有研究检查这些设备的经济影响,而且现有研究并不完整。因此,计划实施这些设备的医院将无法进行合理的经济评估。需要对 CSTD 进行强有力的经济评估。